Huifeng Hao

Huifeng Hao

UNVERIFIED PROFILE

Are you Huifeng Hao?   Register this Author

Register author
Huifeng Hao

Huifeng Hao

Publications by authors named "Huifeng Hao"

Are you Huifeng Hao?   Register this Author

5Publications

103Reads

30Profile Views

Marsdenia tenacissima extract dilated small mesenteric arteries via stimulating endothelial nitric oxide synthase and inhibiting calcium influx.

J Ethnopharmacol 2019 Jun 1;238:111847. Epub 2019 Apr 1.

Department of Integration of Chinese and Western Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2019.111847DOI Listing
June 2019

The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury.

Nat Commun 2019 04 23;10(1):1888. Epub 2019 Apr 23.

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09492-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478873PMC
April 2019

Thrombotic Regulation From the Endothelial Cell Perspectives.

Arterioscler Thromb Vasc Biol 2018 Jun;38(6):e90-e95

From the State Key Laboratory of Cardiovascular Disease (M.W., H.H., L.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.118.310367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218174PMC
June 2018

Loss of Endothelial CXCR7 Impairs Vascular Homeostasis and Cardiac Remodeling After Myocardial Infarction: Implications for Cardiovascular Drug Discovery.

Circulation 2017 Mar 2;135(13):1253-1264. Epub 2017 Feb 2.

From State Key Laboratory of Cardiovascular Disease (H.H., Sheng Hu, D.B., L.Z., C.X., F.C., X.H., Shengshou Hu, M.W.), Animal Experimental Center (Y.T.), Department of Cardiovascular Surgery (X.S., Shengshou Hu), and Clinical Pharmacology Center (M.W.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Pharmacology, Shihezi University, Shihezi, Xinjiang, China (C.X.); Faculty of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China (F.C.); Ansary Stem Cell Institute and Department of Genetic Medicine, Weill Cornell Medicine, New York, NY (B.D.); and State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (D.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.023027DOI Listing
March 2017